Skip to main content

Table 1 Characteristics

From: Patients with acute exacerbation of chronic obstructive pulmonary disease feel safe when treated at home: a qualitative study

Hospital at home treatment programme Hospital care
On admission
Sex Female Female Female Male Male Male Female Female Male
Age (yrs) 51 71 71 70 71 79 54 77 77
Marital status Married Widow Widow Married Married Married Divorced Widow Married
Comorbidities Anxiety Depression Heart Disease Hypertension Heart Disease Hypertension Hypertension Diabetes mellitus Hypertension Diabetes mellitus Hypertension Anxiety Diabetes mellitus Inflammatory bowel disease Heart disease
GOLD stage II I III III III II III III III
Blood pressure (mmHg) 150/80 180/80 140/75 155/90 150/90 140/70 140/75 150/80 97/53
Pulse rate min-1 108 56 87 75 88 61 105 110 60
PaO2 (kPa) 8.27 8.45 10.9 7.57 11.4 8.93 9.18 8.74 8.13
Respiratory rate min-1 24 22 20 35 24 18 17 20 25
Number of drugs 5 8 8 5 8 10 5 8 8
At 6 weeks control
FEV1 (l/s) (% of predicted) 1.68 (59%) 1.89 (97%) 0.5 (31%) 1.4 (37%) 1.3 (40%) 2.1 (75%) 0.9 (39%) 0.8 (41%) 1.3 (42%)
MRC dyspnoea scale 5 3 3 2 2 2 3 4 2
BMI (kg/m2) 41 33 24 38 33 30 30 26 24
6-minute walk test (m) * 508 272 500 125 510 280 350 500
  1. IBD: Inflammatory bowel disease; GOLD: Global Initiative for Chronic Obstructive Lunge Disease; PaO2: arterial oxygen tension; FEV1: forced expiratory volume in one second; MRC: Medical Research Council dyspnoea scale, range (1–5); BMI: Body mass index; *not carried out due to a knee injury.